183 related articles for article (PubMed ID: 23249501)
1. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
Thwaites G; Auckland C; Barlow G; Cunningham R; Davies G; Edgeworth J; Greig J; Hopkins S; Jeyaratnam D; Jenkins N; Llewelyn M; Meisner S; Nsutebu E; Planche T; Read RC; Scarborough M; Soares M; Tilley R; Török ME; Williams J; Wilson P; Wyllie S; Walker AS;
Trials; 2012 Dec; 13():241. PubMed ID: 23249501
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
Thwaites GE; Scarborough M; Szubert A; Nsutebu E; Tilley R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS;
Lancet; 2018 Feb; 391(10121):668-678. PubMed ID: 29249276
[TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trial.
Szubert A; Bailey SL; Cooke GS; Peto T; Llewelyn MJ; Edgeworth JD; Walker AS; Thwaites GE;
J Infect; 2019 Oct; 79(4):332-340. PubMed ID: 31398375
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
Forsblom E; Ruotsalainen E; Järvinen A
PLoS One; 2015; 10(4):e0122824. PubMed ID: 25874546
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review.
Russell CD; Lawson McLean A; Saunders C; Laurenson IF
J Med Microbiol; 2014 Jun; 63(Pt 6):841-848. PubMed ID: 24623637
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
Trials; 2018 May; 19(1):297. PubMed ID: 29843781
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of adjunctive rifampicin for treatment of Staphylococcus aureus bacteraemia: a systematic review and meta-analysis of randomized controlled trials.
Dotel R; Gilbert GL; Hutabarat SN; Davis JS; O'Sullivan MVN
J Antimicrob Chemother; 2023 Oct; 78(10):2419-2427. PubMed ID: 37583062
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus.
Yzerman EP; Boelens HA; Vogel M; Verbrugh HA
J Antimicrob Chemother; 1998 Aug; 42(2):233-9. PubMed ID: 9738842
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX;
BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161
[TBL] [Abstract][Full Text] [Related]
13. Interventions to reduce Staphylococcus aureus in the management of eczema.
George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.
Ma H; Cheng J; Peng L; Gao Y; Zhang G; Luo Z
PLoS One; 2020; 15(3):e0230383. PubMed ID: 32191760
[TBL] [Abstract][Full Text] [Related]
15. Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible
Grillo S; Cuervo G; Carratala J; San-Juan R; Aguado JM; Morata L; Gomez-Zorrilla S; López-Contreras J; Gasch O; Gomila-Grange A; Iftimie S; Garcia-Pardo G; Calbo E; Boix-Palop L; Oriol I; Jover-Sáenz A; López-Cortés LE; Euba G; Aguirregabiria M; Garcia-Pais MJ; Gioia F; Paño JR; Pedro-Botet ML; Benítez RM; Pérez-Rodríguez MT; Meije Y; Loeches-Yagüe MB; Horna G; Berbel D; Domínguez MÁ; Padullés A; Cobo S; Hereu P; Videla S; Tebe C; Pallarés N; Miro JM; Pujol M;
BMJ Open; 2021 Aug; 11(8):e051208. PubMed ID: 34353808
[TBL] [Abstract][Full Text] [Related]
16. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocol.
Daneman N; Rishu AH; Pinto RL; Arabi YM; Cook DJ; Hall R; McGuinness S; Muscedere J; Parke R; Reynolds S; Rogers B; Shehabi Y; Fowler RA;
BMJ Open; 2020 May; 10(5):e038300. PubMed ID: 32398341
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment duration and prevention of complications in neonatal Staphylococcus aureus bacteraemia.
Kempley S; Kapellou O; McWilliams A; Banerjee J; McCorqodale A; Millar M
J Hosp Infect; 2015 Oct; 91(2):129-35. PubMed ID: 26320613
[TBL] [Abstract][Full Text] [Related]
18. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
19. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
[TBL] [Abstract][Full Text] [Related]
20. Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with
Weis S; Hagel S; Schmitz RP; Scherag A; Brunkhorst FM; Forstner C; Löffler B; Pletz MW
BMJ Open; 2017 Apr; 7(4):e013976. PubMed ID: 28391236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
